Checked
Nodthera Inc.
RZRA · Pharmaceutical Preparations · Boston, MA
- Last filing
- 10/21/2026
- Filings on record
- 4
Company details
As reported to the SEC
- SEC CIK
- 2141583
- Stock
- RZRA
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- Headquarters
- 265 Franklin St., Suite 1702, Boston, MA 02110
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Phone
- (617) 694-2481
- Employer ID (EIN)
- 87-4018930
No annual XBRL financial data in U.S. dollars is available for this company. Funds, very new registrants, and some foreign companies that report in other currencies do not have it. See the filings below or on EDGAR.
Recent filings
4 recent filings on record
Swipe the table sideways to see more columns.
| Form | Filed | Period |
|---|---|---|
| S-1Registration statement (new securities) | 10/21/2026 | None |
| DRS/ASEC filing | 09/22/2026 | None |
| DRS/ASEC filing | 08/21/2026 | None |
| DRSSEC filing | 07/07/2026 | None |
Other pharmaceutical preparations
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Johnson & JohnsonJNJ | New Brunswick, NJ | $94.19B | $26.8B |
| Eli Lilly & CoLLY | Indianapolis, IN | $65.18B | $20.64B |
| Merck & Co., Inc.MRK | Rahway, NJ | $65.01B | $18.25B |
| Pfizer IncPFE | New York, NY | $62.58B | $7.77B |
| AbbVie Inc.ABBV | North Chicago, IL | $61.16B | $4.23B |
| Astrazeneca PLCAZN | Cambridge, United Kingdom | $58.74B | $10.22B |
| Bristol Myers Squibb CoBMY | Princeton, NJ | $48.19B | $7.05B |
| Abbott LaboratoriesABT | Abbott Park, IL | $44.33B | $6.52B |
Profile refreshed Oct 26, 2026; financials refreshed Oct 26, 2026.
Frequently asked questions
- What is Nodthera Inc.'s CIK number?
- Nodthera Inc.'s SEC Central Index Key (CIK) is 2141583.
- What is Nodthera Inc.'s stock ticker?
- Nodthera Inc. trades as RZRA.
- When does Nodthera Inc.'s fiscal year end?
- Nodthera Inc.'s fiscal year end on file with the SEC is December 31.
- Where is Nodthera Inc. headquartered?
- Nodthera Inc.'s principal executive office on file with the SEC is in Boston, MA.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026